{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:16:04Z","timestamp":1763057764957},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jcv.2013.06.024","type":"journal-article","created":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T15:03:20Z","timestamp":1373987000000},"page":"279-282","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Analysis of HHV-6 mutations in solid organ transplant recipients at the onset of cytomegalovirus disease and following treatment with intravenous ganciclovir or oral valganciclovir"],"prefix":"10.1016","volume":"58","author":[{"given":"Lotfi","family":"Bounaadja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelyne","family":"Piret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Goyette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Boivin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2013.06.024_bib0005","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00705-012-1299-6","article-title":"Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2012)","volume":"157","author":"Adams","year":"2012","journal-title":"Arch Virol"},{"key":"10.1016\/j.jcv.2013.06.024_bib0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1086\/317929","article-title":"Human beta-herpesvirus interactions in solid organ transplant recipients","volume":"183","author":"Mendez","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2013.06.024_bib0015","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1086\/314510","article-title":"Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection","volume":"178","author":"DesJardin","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2013.06.024_bib0020","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1086\/323336","article-title":"Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated disease in orthotopic liver transplant recipients","volume":"33","author":"DesJardin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcv.2013.06.024_bib0025","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1034\/j.1399-0012.2003.02104.x","article-title":"Detection of simultaneous beta-herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection","volume":"17","author":"Razonable","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jcv.2013.06.024_bib0030","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/jmv.20626","article-title":"HHV-6 and HHV-7 antigenemia related to CMV infection after liver transplantation","volume":"78","author":"Harma","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.jcv.2013.06.024_bib0035","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1128\/CMR.18.1.217-245.2005","article-title":"Update on human herpesvirus 6 biology, clinical features, and therapy","volume":"18","author":"De Bolle","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jcv.2013.06.024_bib0040","series-title":"Human herpesvirus 6: general virology, epidemiology and clinical pathology","first-page":"291","article-title":"Therapeutic approaches to HHV-6 infection","author":"Naesens","year":"2006"},{"key":"10.1016\/j.jcv.2013.06.024_bib0045","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/358162a0","article-title":"A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells","volume":"358","author":"Sullivan","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jcv.2013.06.024_bib0050","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/358160a0","article-title":"Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral ganciclovir","volume":"358","author":"Littler","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jcv.2013.06.024_bib0055","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/JVI.73.4.3284-3291.1999","article-title":"The U69 gene of human herpesvirus 6 encodes a protein kinase which can confer ganciclovir sensitivity to baculoviruses","volume":"73","author":"Ansari","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.jcv.2013.06.024_bib0060","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1016\/S0021-9258(18)83248-3","article-title":"Herpes simplex virus type 1 DNA polymerase. Mechanism of inhibition by acyclovir triphosphate","volume":"264","author":"Reardon","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcv.2013.06.024_bib0065","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/CMR.00009-10","article-title":"Antiviral drug resistance of human cytomegalovirus","volume":"23","author":"Lurain","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jcv.2013.06.024_bib0070","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/j.1600-6143.2007.01910.x","article-title":"Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients","volume":"7","author":"Asberg","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jcv.2013.06.024_bib0075","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1600-6143.2009.02617.x","article-title":"Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients","volume":"9","author":"Asberg","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jcv.2013.06.024_bib0080","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-6143.2005.01207.x","article-title":"American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation","volume":"6","author":"Humar","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jcv.2013.06.024_bib0085","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1177\/135965350901400512","article-title":"Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir","volume":"14","author":"Boivin","year":"2009","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jcv.2013.06.024_bib0090","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jcv.2006.12.019","article-title":"Human herpesvirus-6 (HHV-6) DNA in plasma reflects the presence of infected blood cells rather than circulating viral particles","volume":"38","author":"Achour","year":"2007","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2013.06.024_bib0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0166-0934(01)00390-1","article-title":"Development of a real-time polymerase chain reaction assay for the diagnosis of human herpesvirus-6 infection and application to bone marrow transplant patients","volume":"100","author":"Gautheret-Dejean","year":"2002","journal-title":"J Virol Methods"},{"key":"10.1016\/j.jcv.2013.06.024_bib0100","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1128\/JCM.03234-12","article-title":"Evaluation of Epstein-Barr virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time PCR-based assays","volume":"51","author":"Bounaadja","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2013.06.024_bib0105","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/rmv.715","article-title":"Chromosomally integrated human herpesvirus 6: questions and answers","volume":"22","author":"Pellett","year":"2012","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.jcv.2013.06.024_bib0110","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1600-6143.2008.02501.x","article-title":"An assessment of herpesvirus co-infections in patients with CMV disease: correlation with clinical and virologic outcomes","volume":"9","author":"Humar","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jcv.2013.06.024_bib0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jcv.2008.09.002","article-title":"Human herpesvirus 6 ganciclovir-resistant strain with amino acid substitutions associated with the death of an allogeneic stem cell transplant recipient","volume":"44","author":"Isegawa","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2013.06.024_bib0120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s13365-011-0019-4","article-title":"Ganciclovir-resistant human herpesvirus-6 encephalitis in a liver transplant patient: a case report","volume":"17","author":"Baldwin","year":"2011","journal-title":"J Neurovirol"},{"key":"10.1016\/j.jcv.2013.06.024_bib0125","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1099\/0022-1317-82-11-2767","article-title":"Selection of the same mutation in the U69 protein kinase gene of human herpesvirus-6 after prolonged exposure to ganciclovir in vitro and in vivo","volume":"82","author":"Manichanh","year":"2001","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jcv.2013.06.024_bib0130","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/jmv.10510","article-title":"Mapping ganciclovir resistance in the human herpesvirus-6 U69 protein kinase","volume":"71","author":"Safronetz","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.jcv.2013.06.024_bib0135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jviromet.2009.06.016","article-title":"Detection and identification of U69 gene mutations encoded by ganciclovir-resistant human herpesvirus 6 using denaturing high-performance liquid chromatography","volume":"161","author":"Nakano","year":"2009","journal-title":"J Virol Methods"},{"key":"10.1016\/j.jcv.2013.06.024_bib0140","doi-asserted-by":"crossref","first-page":"19138","DOI":"10.1073\/pnas.0908504106","article-title":"Cloning human herpes virus 6A genome into bacterial artificial chromosomes and study of DNA replication intermediates","volume":"106","author":"Borenstein","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcv.2013.06.024_bib0145","doi-asserted-by":"crossref","first-page":"8492","DOI":"10.1128\/JVI.00504-12","article-title":"Complementation of the function of glycoprotein H of human herpesvirus 6 variant A by glycoprotein H of variant B in the virus life cycle","volume":"86","author":"Oyaizu","year":"2012","journal-title":"J Virol"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653213002564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653213002564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T06:32:26Z","timestamp":1688365946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653213002564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1386653213002564"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2013.06.024","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of HHV-6 mutations in solid organ transplant recipients at the onset of cytomegalovirus disease and following treatment with intravenous ganciclovir or oral valganciclovir","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2013.06.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}